Detailed answers about TOREKON MEDICAL CONSULTING LTD, including incorporation, status, business activity, and accounts information.
When was TOREKON MEDICAL CONSULTING LTD founded?
TOREKON MEDICAL CONSULTING LTD was officially incorporated on 16 June 2025 and is registered under company number 16521568. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is TOREKON MEDICAL CONSULTING LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of TOREKON MEDICAL CONSULTING LTD?
TOREKON MEDICAL CONSULTING LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does TOREKON MEDICAL CONSULTING LTD do?
TOREKON MEDICAL CONSULTING LTD operates in the following sectors: 46460 - Wholesale of pharmaceutical goods, 47749 - Retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c., 86210 - General medical practice activities, 86220 - Specialists medical practice activities. These SIC codes provide insight into the company's business activities and industry focus.
What is TOREKON MEDICAL CONSULTING LTD's registered address?
The registered office address of TOREKON MEDICAL CONSULTING LTD is 21 NUTBROWNE ROAD, DAGENHAM, ENGLAND, RM9 6BQ. This is the official address filed with Companies House for legal and statutory correspondence.
Is TOREKON MEDICAL CONSULTING LTD financially stable?
Financial accounts for TOREKON MEDICAL CONSULTING LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.